Showing results (51-60 of 193) with videos related to
Sort By:
Pageof 20
Analytica Chimica Acta|February 21, 2019
Highly efficient Polyaniline-MoS2 hybrid nanostructures based biosensor for cancer biomarker detectionAmrita Soni, Chandra Mouli Pandey, Manoj Kumar Pandey, et al.Solid State Nuclear Magnetic Resonance|January 10, 2019
Proton-detected 3D 1H anisotropic/14N/1H isotropic chemical shifts correlation NMR under fast magic angle spinning on solid samples without isotopic enrichmentManoj Kumar Pandey, Joshua T Damron, Ayyalusamy Ramamoorthy, et al.Solid State Nuclear Magnetic Resonance|August 9, 2025
Measurement of C-H distances in solids at natural abundance via proton-detected fast MAS NMR spectroscopyYayatika Bhardwaj, Ketan Kumar Rohilla, Yusuke Nishiyama, et al.Developmental Disabilities Research Reviews|June 26, 2013
Neuronopathic lysosomal storage diseases: clinical and pathologic findingsCarlos E Prada, Gregory A GrabowskiAnnual Review of Genomics and Human Genetics|October 7, 2003
Enzyme therapy for lysosomal storage disease: principles, practice, and prospectsGregory A Grabowski, Robert J HopkinClinical Investigation|September 20, 2011
Velaglucerase alfa in the treatment of Gaucher disease type 1Thomas A Burrow, Gregory A GrabowskiMolecular Genetics and Metabolism|February 8, 2005
Translation modulation of acid beta-glucosidase in HepG2 cells: participation of the PKC pathwayYou-Hai Xu, Gregory A GrabowskiFrontiers in Neurology|July 9, 2021
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's DiseaseAlbert Frank Magnusen, Shelby Loraine Hatton, Reena Rani, et al.The Journal of Biological Chemistry|June 19, 2003
Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradationYing Sun, Xiaoyang Qi, Gregory A GrabowskiAmerican Journal of Hematology|June 23, 2015
Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher RegistryGregory A Grabowski, Ari Zimran, Hiroyuki IdaPageof 20